RA Capital Management »

Aerovate Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 9.2M 1.66
2024-03-31 $244M 8.3M 29.57
2023-12-31 $187M 8.3M 22.63
2023-09-30 $112M 8.3M 13.57
2023-06-30 $142M 8.3M 17.15
2023-03-31 $167M 8.3M 20.17
2022-12-31 $242M 8.3M 29.30
2022-09-30 $137M 8.3M 16.58
2022-06-30 $129M 8.3M 15.63
2022-03-31 $152M 8.3M 18.33
2021-12-31 $97M 8.3M 11.79
2021-09-30 $173M 8.3M 20.98
2021-06-30 $189M 8.3M 22.83